PlainPill

Clomiphene vs Testosterone for hormones

Short answer: For hormones, users rate them about the same: 95% report improvement with Clomiphene (64 reports) and 91% with Testosterone (101 reports).

Clomiphene has 218 meta-analyses and 531 randomized trials on PubMed; Testosterone has 75 and 125.

Based on 224 reports about Clomiphene and 924 about Testosterone. Not medical advice.

Clomiphene
Medication
Testosterone
Medication
Users say it helped53%helped76 reports · medium confidence76%helped425 reports · high confidence
Verdict
Mixed
Mostly positive
ResearchAResearch: StrongAResearch: Strong
Meta-analyses / RCTs218 / 53175 / 125
Mainly used for
Performance
% reporting improvement
80% (5)98% (180)
Hormones
% reporting improvement
95% (64)91% (101)
Mood
% reporting improvement
22% (23)89% (117)
Energy
% reporting improvement
67% (6)93% (88)
Libido
% reporting improvement
50% (10)90% (78)
Common side effectsmood swings, emotional, fatigue, vision sidessuppression, hair loss, acne, water retention
Typical dose reportedNot listedNot listed
Clomiphene
Latest review conclusion

Clomiphene citrate increased sperm concentration and motility and could be considered as a safe therapy for improving sperm parameters in infertile males.

Andrology, 2023 ↗
What a user said
“At 35 years old, I literally feel as good as I did in high school again in every aspect: motivation, libido, energy, wellbeing, etc.”
Full Clomiphene profile →
Testosterone
Latest review conclusion

The guidelines also provide recommendations regarding identification of patients, dosing, monitoring, and follow-up. This Practice Pearl will discuss evidence-based testosterone therapy for management of HSDD in postmenopausal women.

Menopause, 2023 ↗
What a user said
“Feel the best I've ever felt in my life. TRT and peptides have been game changers for me!”
Full Testosterone profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate